https://www.selleckchem.com/products/mf-438.html
4%[n=1] vs 2.4%[n=253], P=0.25). The IT and PC groups had similar overall survival (5-year survival 63% [95% CI, 50-74] vs 51% [95% CI, 50-52]; log-rank P=0.06; multivariable adjusted hazard ratio 0.98 [95% CI, 0.67-1.41], P=0.9. A propensity score-matched analysis of 344 patients, well-matched by preoperative characteristics, showed no significant differences in short-term outcomes and overall survival (log-rank P=1.0 between the two groups. In this national analysis, preoperative immunotherapy followed by surgery for NSCLC was foun
Like
Comment
Share
